関連する実験動画
Updated: May 5, 2026

09:17
Using Retinal Imaging to Study Dementia
Published on: November 7, 2017
21.1K
アンサンブル機械学習分類器を用いた光干渉断層撮影血管造影によるパーキンソン病診断
MohammadReza Hasanshahi1, Alireza Mehdizadeh2,3, Tahereh Mahmoudi4,5,6
1Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Scientific reports
|February 4, 2026
まとめ
光干渉断層撮影血管造影(OCTA)によって検出された網膜微小血管の変化は、パーキンソン病の早期診断のための非侵襲的バイオマーカーとして有望視されている。
科学分野:
- 眼科学
- 神経学
- 医用画像
背景:
- パーキンソン病(PD)の診断は、早期バイオマーカーの欠如により困難である。
- OCTAによって検出される網膜微小血管の変化は、潜在的な非侵襲的PDバイオマーカーとして注目されている。
- 客観的かつ非侵襲的なツールは、タイムリーなPD検出と介入に不可欠である。
研究 の 目的:
- OCTA由来の網膜血管特徴のパーキンソン病分類への有用性を調査すること。
- 網膜画像データを用いたPD検出のための機械学習モデルを開発・検証すること。
主な方法:
- 53人のPD患者と39人の健常対照群から得られたOCTA画像の回顧的分析。
- 表層および深層血管複合体のセグメンテーションを行い、22の定量的特徴を抽出。
- 多段階特徴選択フレームワークとアンサンブル機械学習モデル(XGBoost、Random Forest、KNN)の適用。
主要な成果:
- 独立したテストセットで74.28%の精度、90%の感度、53.33%の特異度、0.75のAUCを達成したアンサンブルモデル。
- 主要な特徴には、形態学的記述子(形状係数、凸性、固形性、円形度)および血管密度(VAD、VSD)が含まれていた。
- 臨床応用のため、ユーザーフレンドリーなグラフィカルインターフェイス(PDAI)を開発した。
結論:
- OCTAベースの網膜血管解析は、パーキンソン病の分類とスクリーニングのための有望な非侵襲的アプローチを提供する。
- 開発されたAIフレームワークは、早期PD検出をサポートするが、より大規模な多施設研究でのさらなる検証が必要である。
関連する概念動画
Computed Tomography
7.6K
Tomography refers to imaging by sections. Computed tomography (CT) is a non-invasive imaging technique that uses computers to analyze several cross-sectional X-rays to reveal minute details about structures in the body.
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
7.6K
Positron Emission Tomography
6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28

